![]() |
Volumn 12, Issue 4, 2002, Pages 571-574
|
Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIRICODAR;
CYCLOSPORIN;
DAUNORUBICIN;
DOXORUBICIN;
ELACRIDAR;
GLYCOPROTEIN P;
MULTIDRUG RESISTANCE PROTEIN 1;
OC 144093;
PROTEIN INHIBITOR;
QUINAZOLINONE DERIVATIVE;
TARIQUIDAR;
UNCLASSIFIED DRUG;
ZOSUQUIDAR;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
QUINAZOLINE DERIVATIVE;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG CYTOTOXICITY;
DRUG POTENCY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
LUNG NON SMALL CELL CANCER;
MULTIDRUG RESISTANCE;
PROTEIN ANALYSIS;
PROTEIN SYNTHESIS INHIBITION;
STRUCTURE ACTIVITY RELATION;
CELL CULTURE;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG INTERACTION;
IC 50;
SYNTHESIS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
DAUNORUBICIN;
DOXORUBICIN;
DRUG INTERACTIONS;
DRUG RESISTANCE, MULTIPLE;
HUMANS;
INHIBITORY CONCENTRATION 50;
P-GLYCOPROTEIN;
QUINAZOLINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR CELLS, CULTURED;
|
EID: 12444318333
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00804-6 Document Type: Article |
Times cited : (31)
|
References (27)
|